Peptide Profile
Thymosin Alpha-1
Your immune system's master trainer—a naturally occurring thymus peptide that wakes up tired immune cells, helps your body fight infections, and keeps your defenses sharp as you age.
Dose Range
1.6-3.2mg
Frequency
Twice weekly
Route
Subcutaneous injection
Cycle Length
8-12 weeks
Onset
Moderate (1-2 weeks)
Evidence
Moderate
Compound Profile
Scientific & Efficacy Data
C129H215N33O55
Molecular Formula
3108.32 g/mol
Molecular Weight
Approximately 2 hours
Half-Life
High when injected subcutaneously (rapid absorption, peak at ~2 hours)
Bioavailability
62304-98-7
CAS #
16130571
PubChem ID ↗
Developed By · 1972
Allan L. Goldstein, PhD
University of Texas Medical Branch / George Washington University
Primary Benefits
Directly enhances T-cell and dendritic cell function with extensive clinical validation across thousands of patients
Proven efficacy against chronic hepatitis B/C with improved viral clearance rates in multiple controlled trials
Unique ability to boost immunity while preventing harmful overreaction through IDO pathway activation
Amino Acid Sequence
Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn (Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN)Dosing
How much
do I take?
Starting Dose
1.6 mg
This is the standard clinical dose used in most research trials. Start here to assess your tolerance and response. The 1.6 mg dose (sometimes listed as 900 mcg/m2) has decades of safety data behind it.
Standard Dose
1.6 mg
The most common protocol used in clinical trials for hepatitis and cancer support. Inject on consistent days (like Monday/Thursday) for best results. This duration allows meaningful immune enhancement.
Advanced Dose
1.6 mg daily for 7 days, then twice weekly
Used in some severe infection and critical care protocols. The daily loading phase rapidly boots immune function, followed by maintenance. Only under medical supervision for serious conditions.
Timing
Best time to take
Morning or early afternoon injections work well for most people. Some prefer morning to align with natural cortisol rhythms and immune activity peaks.
With food?
Can be taken regardless of food. Thymosin Alpha-1 absorption isn't significantly affected by meals, so fit it into whatever schedule works best for you.
If stacking
If using with other peptides like BPC-157, inject at separate sites. Thymosin Alpha-1 works well alongside Thymalin for comprehensive immune support. Space injections at least a few hours apart when stacking.
Adjusting Your Dose
Increase if
- +You've tolerated the starting protocol well for 4+ weeks
- +Your healthcare provider recommends intensification for specific conditions
- +Blood work shows continued immune markers that could benefit from support
Decrease if
- -You experience persistent flu-like symptoms beyond the first week
- -Injection site reactions don't improve with site rotation
- -You develop signs of immune overstimulation (discuss with doctor)
- -Any autoimmune symptoms emerge or worsen
Signs of right dose
- ✓Fewer colds and infections over time
- ✓Faster recovery when you do get sick
- ✓Stable energy levels
- ✓Improved lab markers if tracking immune function
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Suitability
Is this
right for me?
Best For
Chronic Hepatitis B or C Support
Thymosin Alpha-1 has its strongest clinical evidence here. Multiple trials show it helps clear viral loads and normalize liver enzymes, especially when combined with antiviral medications. It's approved in over 30 countries specifically for hepatitis treatment.
Cancer Treatment Support
When used alongside chemotherapy, Thymosin Alpha-1 may help maintain immune function that chemo tends to suppress. Research in lung cancer, melanoma, and liver cancer shows improved outcomes when added to standard treatments. It helps your immune system keep fighting even during tough treatments.
Age-Related Immune Decline
As you age, your thymus shrinks and produces less thymosin naturally—a process called immunosenescence. Supplementing with Thymosin Alpha-1 may help compensate, keeping your immune defenses more youthful and responsive. Think of it as replacing what your body makes less of over time.
Severe Infection Recovery
In sepsis and critical infections, Thymosin Alpha-1 has shown promise for reducing mortality by helping restore immune balance. It's particularly interesting because it modulates immunity rather than just boosting it—calming overreaction while enhancing pathogen-fighting ability.
Consider Alternatives If
Who Should Avoid
Do not use if
- ×You've had an organ transplant and take immunosuppressants—Thymosin Alpha-1 could trigger rejection
- ×You have an active autoimmune disease flare—immune stimulation could worsen symptoms
- ×You're pregnant or breastfeeding—safety not established in these populations
- ×You've ever had a severe allergic reaction to any thymosin peptide
- ×You're under 18 without specific medical supervision for immune disorders
Use with caution if
- !You have any autoimmune condition, even in remission—monitor closely for flares
- !You take medications that affect immune function—timing and interactions matter
- !You have a history of allergic reactions to peptides or injected medications
- !You're on cancer immunotherapy—effects may combine unpredictably
- !You have kidney or liver disease—may affect clearance
- !You're elderly with multiple medications—discuss potential interactions
Administration
How do I
use it?
Reconstitution
What you need
- •Bacteriostatic water (BAC water)—the preservative keeps it safe for multiple doses
- •Insulin syringes (29-31 gauge) for precise dosing
- •Alcohol swabs for cleaning vial tops and injection sites
- •Your Thymosin Alpha-1 powder vial
Injection
Route
Subcutaneous injection (just under the skin)—this is how it was used in all major clinical trials and provides reliable absorption
Best sites
- •Abdominal area (2 inches away from navel)
- •Front or outer thigh
- •Back of upper arm
Technique
- 1.Wash hands thoroughly with soap and water
- 2.Clean the injection site with an alcohol swab and let it dry completely
- 3.Pinch about an inch of skin to create a small fold
- 4.Insert needle at 45-90 degree angle (45 if lean, 90 if more tissue)
- 5.Inject slowly and steadily over several seconds
- 6.Release the pinch, wait a moment, then withdraw needle
- 7.Apply light pressure if needed—don't rub the area
Storage
Signs of degradation
Sample Daily Schedule
Safety
Is it
safe?
Safety Profile
Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries. Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life means it doesn't accumulate in your system. It's been used safely in thousands of patients with hepatitis, cancer, and other serious conditions.
Safety data comes from numerous Phase I-III clinical trials and post-marketing surveillance in countries where it's approved (China, Russia, and 30+ other nations). The FDA has granted orphan drug status for hepatocellular carcinoma and approved it for certain uses. Most serious adverse events in studies were related to underlying conditions, not the peptide itself.
Common Side Effects
Experienced by some users
Injection site reactions
Redness, mild swelling, or discomfort where you injected is the most frequently reported effect. It's your skin's normal response to the injection process.
Management: Rotate injection sites with each dose. Ice the area briefly if uncomfortable. These reactions typically resolve within 24-48 hours.
Mild fatigue
Some users feel a bit tired after their injection, especially in the first few doses. Your immune system is activating and that takes energy.
Management: Time your injections for when you can rest if needed. Most people find this improves after the first week as their body adjusts.
Flu-like symptoms
Mild muscle aches, low-grade warmth, or general 'blah' feeling in the first few doses. This is actually a sign your immune system is responding.
Management: Stay hydrated and rest. These symptoms usually fade quickly and don't return with continued dosing. If severe or persistent, reduce frequency.
Less Common
- •Mild fever
- •Lymph node awareness
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
- ×Any signs of allergic reaction—stop immediately and seek medical help
- ×Worsening of any autoimmune symptoms you may have
- ×Persistent fever above 101°F that doesn't resolve
- ×Severe or spreading injection site reactions
- ×Any new symptoms that concern you or feel abnormal
- ×Completion of your prescribed treatment cycle
Thymosin Alpha-1 is approved for specific uses in some countries but remains a research compound for other applications. Always work with a qualified healthcare provider when using any peptide therapy. This information is educational—not medical advice for your specific situation.
Interactions
With other peptides
- ✓Excellent pairing—both support thymus function through complementary mechanisms. Often used together in immune protocols.
- ✓Safe combination. BPC-157 focuses on healing while Thymosin Alpha-1 handles immune function—different targets, no conflict.
- ✓Can be combined for comprehensive aging support. Epithalon targets telomeres while Thymosin Alpha-1 supports immune aging.
- ✓Same family, different functions. TB-500 is for tissue repair; TA-1 is for immune function. Can be used together safely.
With medications
- !Immunosuppressants (cyclosporine, tacrolimus) - CONTRAINDICATED. Thymosin Alpha-1 stimulates immune function, directly opposing these medications. Could trigger transplant rejection.
- !Corticosteroids (prednisone) - May reduce Thymosin Alpha-1 effectiveness. If you need steroids, timing separation may help. Discuss with your doctor.
- ✓Interferon-alpha - Actually studied together extensively for hepatitis. The combination shows enhanced effectiveness in clinical trials.
- ✓Chemotherapy drugs - Research supports using Thymosin Alpha-1 alongside chemo to maintain immune function. Should be coordinated with oncologist.
With supplements
- ✓Vitamin D - Excellent combination. Vitamin D also supports immune function and may enhance Thymosin Alpha-1 effects.
- ✓Zinc - Safe and complementary. Zinc is essential for immune function and supports T-cell development.
- ✓Glutathione - Good pairing for overall immune and antioxidant support. No known interactions.
- ✓Echinacea - Both stimulate immunity. While likely safe, watch for signs of overstimulation if using together long-term.
Effectiveness
Does it
work?
Evidence Level
Moderate human trials
What to Expect
Week 1-2
What you might notice
- •Mild injection site reactions that improve with rotation
- •Possible flu-like symptoms after first few doses
- •Perhaps slightly more fatigue as immune system activates
- •Nothing dramatic—changes are happening at the cellular level
What's normal
- •Temporary discomfort at injection sites
- •Mild muscle aches or fatigue
- •Feeling 'off' for a few hours after injection
- •Not feeling anything different at all
What's next
- →Side effects typically improve after the first week
- →Continue your twice-weekly schedule consistently
- →Track any effects in a simple journal
Week 3-6
What you might notice
- •Injection tolerance improves significantly
- •Some people report feeling more resilient to minor bugs
- •Energy levels may stabilize or improve
- •If fighting infection, viral markers may start improving
What's normal
- •Settled into routine with minimal side effects
- •Gradual sense of improved resilience
- •Lab work showing immune marker changes (if testing)
What's next
- →Continue consistent dosing schedule
- →This is when clinical benefits typically become measurable
- →Consider lab testing if tracking immune function
Week 7-12+
What you might notice
- •Established benefits maintained
- •Noticeably fewer or shorter illnesses for some users
- •Improved lab markers if monitoring
- •Overall sense of immune competence
What's normal
- •Minimal to no side effects at this stage
- •Benefits feel 'normal'—you might only notice when you stop
- •Stable immune function markers
What's next
- →Discuss with provider whether to continue or cycle off
- →Some protocols continue long-term; others take breaks
- →Long-term safety data supports extended use when indicated
Signs It's Working
General Immune Resilience
- ✓Fewer colds or respiratory infections
- ✓Faster recovery when you do get sick
- ✓Less severe symptoms when exposed to illness
- ✓Improved energy and fewer 'run down' periods
Laboratory Markers (if testing)
- ✓Improved T-cell counts or function
- ✓Normalized liver enzymes (for hepatitis)
- ✓Reduced viral load measurements
- ✓Better NK (natural killer) cell activity
Condition-Specific Improvements
- ✓Hepatitis: Normalized ALT/AST, reduced HBV DNA levels
- ✓Cancer adjunct: Maintained white blood cell counts during chemo
- ✓General: Fewer infections requiring antibiotics
- ✓Faster wound healing and recovery from illness
Not Seeing Results?
Common reasons
- •Expecting immediate results—immune modulation takes weeks to months, not days
- •Inconsistent dosing—skipping doses or irregular scheduling reduces effectiveness
- •Poor quality peptide—always verify third-party testing and proper storage
- •Degraded product—check for cloudiness or particles before each use
- •Underlying condition too severe—Thymosin Alpha-1 supports but doesn't replace primary treatment
- •Unrealistic expectations—it enhances immune function, not replaces it entirely
Key Research
"Historical review on thymosin α1 in oncology: preclinical and clinical experiences"
Garaci E, Pica F, Matteucci C, 2015
Finding: This comprehensive review showed that Thymosin Alpha-1 combined with chemotherapy improved outcomes in melanoma and lung cancer patients. The peptide works on both immune cells and tumor cells, making it uniquely valuable as a cancer adjunct therapy.
View Study"Jack of all trades: thymosin α1 and its pleiotropy"
Romani L, Moretti S, Fallarino F, 2012
Finding: Researchers found that Thymosin Alpha-1 activates multiple immune pathways through Toll-like receptors, enhances dendritic cell function, and importantly activates the IDO enzyme which helps prevent harmful inflammation. This explains how it can both boost immunity AND prevent autoimmune overreaction.
View Study"Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure"
Chen JF, Chen SR, Lei ZY, 2022
Finding: This randomized controlled trial of 120 patients showed that Thymosin Alpha-1 improved 90-day survival from 53% to 75% in severe liver failure patients. It also cut infection rates nearly in half and reduced hepatic encephalopathy risk. Major evidence for serious illness applications.
View Study"Thymosin alpha-1 (Review)"
Ancell CD, Phipps J, Young L, 2001
Finding: This thorough review documented that Thymosin Alpha-1 cleared hepatitis B virus in 40% of treated patients versus only 9% of controls. For hepatitis C, combination with interferon achieved 65% viral clearance versus 29% with interferon alone. The 2-hour half-life and excellent safety profile were confirmed across all trials.
View Study"Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients"
Clinical Trial NCT04428008, 2023
Finding: This Phase 2 trial in 262 dialysis patients (who are highly vulnerable to infections) evaluated whether Thymosin Alpha-1 could prevent COVID-19 infection. The study completed, showing the continued interest in Thymosin Alpha-1 for vulnerable populations facing infectious threats.
View StudyFrequently Asked Questions